Try our Advanced Search for more refined results
December 07, 2012
In Re: Nexium (Esomeprazole) Antitrust Litigation
Case Number:
1:12-md-02409
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Andrews DeValerio
- Baker & Hostetler
- Berger Montague
- Berman Tabacco
- Buchanan Ingersoll
- Carella Byrne
- Cohen Milstein
- Cohn Lifland
- Conn Kavanaugh
- Covington & Burling
- Douglas & London
- Dugan Law Firm
- Faruqi & Faruqi
- Fisher & Phillips
- Foley & Lardner
- FrancoLaw PLLC
- Garwin Gerstein
- Girard Sharp
- Glancy Prongay
- Goldman Scarlato
- Hach & Rose
- Hach Rose Schirripa
- Hagens Berman
- Hamilton Brook
- Hangley Aronchick
- Heim Payne
- Hilliard & Shadowen
- Jones Day
- Justice Law Collaborative
- Kirkland & Ellis
- Korein Tillery
- Lowey Dannenberg
- Marcus & Shapira
- McCarter & English
- Milbank LLP
- Miller Shah LLP
- Mintz Levin
- Morrison Foerster
- Nussbaum Law Group
- Radice Law Firm
- Schnader Harrison
- Scott&Scott
- Shapiro Haber
- Shapiro & Teitelbaum
- Smith Segura Raphael & Leger
- Taus Cebulash
- Venable LLP
- Wexler Boley
- Wilentz Goldman
- Williams & Connolly
- Windels Marx
Companies
- AstraZeneca PLC
- Cardinal Health Inc.
- Careplus Health Plans Inc.
- CVS Health Corp.
- Dr. Reddy's Laboratories Ltd.
- Express Scripts Holding Co.
- Fraternal Order of Police
- Giant Eagle Inc.
- H‑E‑B LP
- Humana Inc.
- McKesson Corp.
- Ranbaxy
- Rite Aid Corp.
- Rochester Drug Cooperative Inc.
- Safeway Inc.
- Supervalu Inc.
- Teva Pharmaceutical Industries Ltd.
- The Kroger Co.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
October 05, 2015
Nexium Buyers Get $8M Fees In Pay-For-Delay Settlement
A Massachusetts federal judge on Monday divvied out more than $8 million in expenses for a settlement reached between Nexium buyers and Teva Pharmaceutical Industries Ltd., but agreed to hold off on approving fees for AstraZeneca PLC and Ranbaxy Inc. following their win in a multidistrict litigation pay-for-delay trial brought by the same buyers.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login